Prostate Cancer: Molecular Events and Therapeutic Modalities

Gautam Sethi, Milad Ashrafizadeh, Nasim Ebrahimi (Herausgeber)

Buch | Hardcover

291 Seiten

2024 | 2025 ed.
Springer Nature (Verlag)
978-981-97-4611-8 (ISBN)

Titel nicht im Sortiment

Artikel merken

The book covers the various cell signaling pathways responsible for prostate cancer progression, conventional therapies used for prostate cancer treatment, new emerging therapeutics, and challenges in the treatment of cancer patients. It describes the different molecular pathways responsible for prostate cancer progression to improve readers' knowledge about the role of signaling networks, and cellular and molecular aspects of prostate cancer progression. These topics include mechanisms responsible for prostate cancer malignancy with a focus on molecular pathways. It also discusses the current challenges in prostate cancer treatment such as drug resistance and immune evasion and introduces novel therapeutics such as gene therapy and nanotherapeutics for prostate cancer.

This book is completely novel and unique and covers all aspects of prostate cancer progression and challenges in therapy while presenting solutions. Written by prestigious researchers around the world, this book will be interesting to researchers and practitioners, especially those working in urological cancers.

Gautam SethiYong Loo Lin School of Medicine, Department of Pharmacology, National University of Singapore, Singapore Milad Ashrafizadeh Faculty of Engineering and Natural Sciences, Sabanci University, Orta Mahalle, Üniversite Caddesi No. 27, Orhanl#, Tuzla, 34956, Istanbul, Turkey, istanbul, Turkey Yuzhuo Wang Department of Urological Sciences and Vancouver Prostate Centre, University of British Columbia, Vancouver, BC V6H3Z6, Canada, British Columbia, Canada

Chapter 1. Anatomy and function of prostate.- Chapter 2. Epidemiology, risk factors and histopathological profile of prostate cancer.- Chapter 3. Prostate cancer and Inflammation.- Chapter 4. Prostate cancer, apoptosis, autophagy and ferroptosis: Cell death mechanisms and their crosstalk.- Chapter 5. Prostate cancer and metastasis: An emphasis on EMT mechanism.- Chapter 6. Prostate cancer and Wnt/STAT3 signaling.- Chapter 7. Prostate cancer and EZH2 signaling.- Chapter 8. Prostate cancer and PTEN/PI3K/Akt/mTOR signaling.- Chapter 9. Prostate cancer and non-coding RNAs: A focus on miRNAs, lncRNAs and circRNAs.- Chapter 10. Prostate cancer and tumor microenvironment.- Chapter 11. Chemoresistance, radioresistance and androgen-deprivation therapy resistance in prostate cancer.- Chapter 12. Plant derived-natural products in treatment of prostate cancer.- Chapter 13. Gene therapy as a new emerging strategy for prostate cancer.- Chapter 14. Nanoparticle-based therapeutic strategies in prostate cancer suppression.

Erscheint lt. Verlag	13.12.2024
Zusatzinfo	16 Illustrations, color; 7 Illustrations, black and white; XXX, 250 p.
Verlagsort	Singapore
Sprache	englisch
Maße	155 x 235 mm
Themenwelt	Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie
	Studium ► 2. Studienabschnitt (Klinik) ► Humangenetik
	Studium ► Querschnittsbereiche ► Epidemiologie / Med. Biometrie
Schlagworte	drug resistance • Nanotechnological approaches • Prostate cancer therapy • Radio-resistance • Signaling networks
ISBN-10	981-97-4611-6 / 9819746116
ISBN-13	978-981-97-4611-8 / 9789819746118
Zustand	Neuware